CRSP CRISPR Therapeutics Inc Yalpi foyda bo'yicha marjinallik

CRISPR Therapeutics Inc (CRSP) korporativ emblemasi va logotipi

Eng yaxshi genetiklarni jalb qilish CRISPR Therapeutics AG (CRSP) texnologik yetakchiligini saqlab qolishini ta'minlaydi, buni yalpi foyda marginining taqsimoti tasdiqlaydi: qiymat -693.20 darajasida barqarorlashgan. Biznes barqarorligi likvidlik va YaIMdan mustaqillik bilan qo'llab-quvvatlanadi. Casgevy tasdiqlanishi bemorlar bazasini kengaytiradi, garchi qat'iy tartibga soluvchi nazorat ushbu innovatsion davolash usullarini tijoriy joriy etish sur'atlarini sekinlashtirayotgan bo'lsa-da.

Yalpi foyda bo'yicha rentabellik: CRISPR Therapeutics AG (CRSP) 04.07.2022 - 20.11.2026 uchun

crisprtx.com (CRSP) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- pul pozitsiyasi va pul oqimlari tafsilotlari:
Fundamental baholash:CRSP, CRISPR Therapeutics Inc
CRISPR Therapeutics AG yetakchi tovari

DNA tahrirlashdagi yuqori xarajatli ishlanmalarga tayanadigan modelga ega bo'lgan CRISPR Therapeutics AG (CRSP) uchun yalpi foyda marjasi intellektual kapitalni monetizatsiya qilish va ishlab chiqarish xarajatlarini boshqarish samaradorligining ko'rsatkichi bo'lib xizmat qiladi. Yalpi foydaning tushumga nisbatini tahlil qilish kompaniyaning asosiy sotuvlar orqali operatsion xarajatlarni qoplash qobiliyatini baholash imkonini beradi va bozor zarbalari oldida biznesning fundamental xavfsiz boshpanasini belgilaydi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|GeneDx - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi RARE|Beam Tx - Yalpi marja|SRPT - Yalpi marja|TWST (Twist Bio) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi rentabelligi TXG|Yalpi foyda bo'yicha rentabellik NTLA|Stoke Therapeutics Inc (STOK) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja BLFS|Yalpi rentabellik WVE (Wave Life Sciences Corp)|Yalpi rentabellik Maze Therapeutics MAZE|Yalpi foyda normasi SION|PRME - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Taysha TSHA|QURE: Yalpi marja|Yalpi foyda bo'yicha rentabellik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Yalpi marja|solidbio.com (SLDB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning yalpi rentabelligi|Benitec Biopharma - Yalpi foyda bo'yicha rentabellik|DSGN: Sotuvning yalpi rentabelligi|RCKT: Yalpi foyda bo'yicha rentabellik|FDMT - Yalpi marja|LXEO: Yalpi marja|Korro Bio Inc. - Yalpi foyda normasi|EDIT (editasmedicine.com) - Yalpi marja|Yalpi rentabellik SLN|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik